Top accelerator startups

14,448 startups · 29 programs

CellType

Active · The agentic drug company. We simulate human biology.

10signal of 100 · rising 10
  • team of 5Team size · YC's directory+4
  • went through YCProgram · this site+4
  • hiringHiring · Titles (titles.fru.dev), YC+2

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W26 in AI

All of W26

Founders

  • David van DijkFounder/CEO
  • Ivan VrkicFounder/CTO

About CellType

CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.

YC batch
W26 · Winter 2026
Status, per YC
Active
Category
AI
Team size
5
Location
New York City, NY, USA
Founded
2025
Checked
6h ago

CellType in W26: 199 companies, 81% AI

LinkedIn

CellType: questions

Which YC batch was CellType in?

CellType was in Y Combinator's Winter 2026 batch (W26).

Is CellType still active?

Y Combinator lists CellType as active.

Who founded CellType?

CellType's founders, as listed on its YC page: David van Dijk (Founder/CEO), Ivan Vrkic (Founder/CTO).

Where is CellType based?

CellType lists New York City, NY, USA as its location on YC's directory.